Peppy&Me COA Standards: What Our Seven-Panel Testing Covers
A certificate of analysis (COA) is only useful if you know what each line proves and what it leaves out. At Peppy&Me, every lot of research peptides is third-party tested for purity, mass accuracy, endotoxins, sterility and heavy metals, and the report is tied to a traceable lot and batch number. This guide treats those five analyses, together with the two identifiers that anchor them (the issuing laboratory and the lot number), as seven checkpoints you can read on any report. It explains what each checkpoint measures, how to verify it, and where its limits lie. All products are sold for laboratory research use only.
TL;DR
- Peppy&Me lots are third-party tested for purity, mass accuracy, endotoxins, sterility and heavy metals, with lot and batch numbers traceable from manufacturer to warehouse.
- Read a COA as seven checkpoints: issuing laboratory, lot number, purity, mass accuracy, endotoxin, sterility and heavy metals.
- A COA describes one batch only. It does not describe other lots, and it does not establish suitability for human or animal use.
- Supplier paperwork can overstate quality, so match the lot number on your vial to the report and consider independent testing for critical work.
- Our dose calculator and peptide glossary help you handle and prepare materials correctly once the paperwork checks out.
What a COA is, and what it must identify
A COA is a batch-specific record. According to a review of certificate completeness in research supply, a report should identify the issuing laboratory, the person who approved the results and the batch or lot number. Without those three, the numbers on the page cannot be tied to anything.
This is why we treat the first two checkpoints as seriously as the chemistry:
- The issuing laboratory. The report should name an independent lab, not only the seller. A reader should be able to see who ran the analysis and who signed it off.
- The lot or batch number. It must match the number printed on the vial you hold. A beautiful report for a different lot proves nothing about your material.
For context on how seriously regulated laboratories treat records, U.S. rules for drug manufacturing require that laboratory records state test results and compare them with established standards of identity, strength, quality and purity. Research-use materials are not pharmaceuticals, but that standard of documentation is the right benchmark for what a good report looks like.
The five analyses behind the testing claim
Peppy&Me states that each lot is third-party tested for the following. Each answers a different question, which is why one number cannot stand in for the rest.
| Checkpoint | Question it answers | What a good report shows |
|---|---|---|
| Purity | How much of the sample is the target peptide, versus related impurities? | A chromatogram and a percentage, with the method named |
| Mass accuracy | Is the molecule the right one? | Measured mass compared with the expected mass |
| Endotoxins | Are bacterial cell-wall fragments present? | A result against a stated limit |
| Sterility | Are viable microorganisms present? | A pass or fail with the method named |
| Heavy metals | Are metallic contaminants present? | Element-level results against stated limits |
Purity
Purity is usually reported by high-performance liquid chromatography (HPLC). The percentage comes from chromatographic peaks: the area of the main peak compared with everything else the detector saw. That is a different quantity from peptide content, which is the share of total peptide relative to other components such as water, counter-ions, residual solvents and salts.
The distinction matters in practice. A vial can be 99% pure by HPLC and still contain a meaningful weight of water and counter-ions, because purity describes the peptide-related fraction, not the whole powder. The same academic review notes that UV detection is not specific for peptide-related impurities and cannot unequivocally identify impurities by retention time and UV absorbance, or quantify those that coelute. So a high purity figure is strong evidence, not a complete portrait.
Mass accuracy
Mass accuracy is the identity check. Mass spectrometry measures the molecular weight of what is in the vial, and the report compares it with the theoretical value. Identity work in pharmacopeial practice relies on several orthogonal techniques, including HPLC coelution against a reference standard and mass spectrometry, because no single technique settles identity alone.
Mass accuracy is especially valuable for look-alike compounds. Our article on TB-500 and thymosin beta-4 shows how two names that are often confused can be very different molecules, and a mass result is how you tell them apart on paper.
Endotoxins
Endotoxins are fragments of bacterial cell walls. They can remain after the organisms are gone, so a sterile sample is not automatically endotoxin-free. USP lists bacterial endotoxin testing under chapter <85> among the quality attributes for synthetic peptides. For cell-culture and in vitro work, endotoxin contamination can quietly distort results, which is one reason this line is on the report.
Sterility
Sterility testing asks whether viable microorganisms are present. The same USP document lists bioburden testing under chapters <61> and <62>. A sterility result is limited to the units sampled, which is a good reason to keep it paired with the lot number and to handle opened vials with aseptic technique.
Heavy metals
Metal catalysts are used in some synthesis routes, and metals can also enter through equipment or raw materials. USP elemental-impurity chapters <232> and <233> describe testing that may be required based on risk assessment or when metal catalysts are used. A heavy-metal panel gives element-level numbers, so you can see what was looked for and what was found.
How to read a COA in five steps
A report is a document you interrogate, not a badge. Work through it in this order.
- Match the lot number. Compare the number on the report with the one on your vial. If you use the QR code on the label, confirm that it leads to the report for that same lot.
- Confirm the laboratory and signature. Look for a named lab, a date and an approving analyst.
- Check the method beside each result. A purity percentage without a method is a number without context. HPLC conditions, mass spectrometry type and endotoxin method should be stated.
- Compare results with stated limits. Pass or fail only means something when the limit is on the page.
- Note what is absent. If an analysis you expect is missing, the report does not cover it.
Laboratory accreditation is another useful signal. ISO/IEC 17025:2017 lets laboratories demonstrate competent operation and valid results. A lab’s scope of accreditation lists the fields, products and methods it is accredited for, and only methods inside that scope may be offered as accredited tests. If you want to go deeper, ask which of the methods on a report fall inside the lab’s scope.
Our own walkthrough, 5 COA tests that prove quality for lab researchers, covers the same ground from the buyer’s side.
What a COA does not tell you
Honest documentation includes honest limits. Three are worth stating plainly.
It covers one batch. A batch-specific COA reports tests and results for the particular material tested. It does not automatically establish the characteristics of other batches, and it does not establish suitability for human or animal administration, as the completeness review puts it. That is why lot traceability matters more than any single headline number.
Supplier paperwork can be wrong, anywhere in the market. A Ghent University study found that only 43 of 98 peptides with certificates claiming at least 95% purity met that specification, and its authors recommended independent quality control rather than relying on supplier certificates alone. We read that as a reason to use independent third-party laboratories, publish batch documentation and encourage verification, not to ask anyone to take our word for it. For critical experiments, consider commissioning your own identity and purity test of a sample.
Third-party tested is not the same as everything tested. A purity report alone says nothing about sterility or endotoxin. That is why the checkpoints above are read together.
Perspective: why we publish lot-level documentation
We built Peppy&Me around a simple belief: a research buyer should never have to guess what is in a vial. That is why every lot is independently tested for purity, mass accuracy, endotoxins, sterility and heavy metals, why lot and batch numbers can be traced from manufacturer to warehouse, and why COA access is a QR scan away.
We also think a COA should be read critically, ours included. The most reassuring thing a supplier can offer is not a perfect number but a document you can check: named laboratory, matching lot, stated method, stated limit. We would rather you verify us than trust us.
On the regulatory side, we are direct about why research peptides sit outside FDA-approved products. Approval requires a very large financial investment, multi-phase clinical trials and commercial backing. Naturally occurring or hard-to-patent compounds often attract less of that funding, even when scientific interest continues. Our products are sold strictly for laboratory research, and we do not make treatment claims. Our article on why some peptides are sold for research use only explains the classification in more detail.
— Peppy&Me
Applying the checklist to specific compounds
The same seven checkpoints apply across the catalog, but different compounds raise different questions.
- GLP-pathway compounds. Semaglutide, tirzepatide and retatrutide have different structures and targets, so identity confirmation matters. Our guide on verifying COAs for semaglutide, tirzepatide and retatrutide walks through what to look for, and the retatrutide and cagrilintide comparison covers assay choices.
- Blends. Multi-ingredient vials need each component identified, not just a single purity figure. See the GLOW blend COA checklist and the KLOW blend guide for examples.
- Copper peptides. Metal content is part of the compound’s identity here, which changes how you read an elemental result. Our GHK-Cu QC and storage guide explains the point.
Beyond the report: handling and preparation
A clean COA describes the material at the time of testing. What happens afterward is up to the lab. Store according to the compound’s documented requirements, keep lot numbers in your records, and note the date each vial is opened. Our peptide glossary collects handling information and research-based background for individual compounds, and the built-in dose calculator helps you work out concentrations accurately for your protocol, so arithmetic errors do not undo careful sourcing.
Where to start
If you are ready to source materials with lot-level documentation, browse the research compounds catalog for peptides, amino acids and derivatives, and blended research materials, or go straight to a product such as semaglutide, tirzepatide or retatrutide. Orders placed before 2 PM ship the same day within the U.S., and real-time support can help with order questions.
Business readers can also look at the private label and dropshipping partnership program, which uses our backend fulfillment and operations. The published terms are a one-off onboarding fee of $500 and an active partnership fee of $99 per month.
FAQ
Does a COA prove a peptide is safe to use?
No. A COA reports the tests and results for one batch of material. It does not establish safety, and it does not establish suitability for human or animal administration. Peppy&Me products are sold for laboratory research only.
How do I know the report matches my vial?
Compare the lot or batch number on the vial label with the one on the report, and use the QR code to open the report tied to that lot. If the numbers differ, treat the report as not applying to your material.
Is a 99% HPLC purity figure the same as 99% peptide content?
Not necessarily. HPLC purity compares peak areas of the target peptide and related impurities, while peptide content accounts for water, counter-ions, residual solvents and salts. Both figures are useful, but they answer different questions.
Why would I test a sample independently if the lot is already third-party tested?
For critical or high-stakes experiments, an independent identity and purity check adds a second line of evidence. Published work on supplier certificates supports that habit, and we welcome it.
Why are research peptides not FDA-approved?
Approval requires large financial investment, clinical trials and commercial backing. Naturally occurring or hard-to-patent compounds often receive less funding despite ongoing scientific interest, so many remain research materials.
Sources
- Completeness of certificates of analysis in research supply
- 21 CFR § 211.194, Laboratory records
- Quality attributes of synthetic peptide drug substances (USP)
- Regulatory and analytical considerations for peptide quality
- Verifying laboratory performance and quality control (GAIN guidance)